These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11768590)

  • 1. Standardisation for in vitro toxicity tests.
    Ferro M; Doyle A
    Cell Biol Toxicol; 2001; 17(4-5):205-12. PubMed ID: 11768590
    [No Abstract]   [Full Text] [Related]  

  • 2. Animal tests inescapable.
    Nature; 2008 May; 453(7195):563-4. PubMed ID: 18509386
    [No Abstract]   [Full Text] [Related]  

  • 3. An assessment of progress in the use of alternatives in toxicity testing since the publication of the report of the second FRAME Toxicity Committee (1991).
    Combes R; Balls M; Bansil L; Barratt M; Bell D; Botham P; Broadhead C; Clothier R; George E; Fentem J; Jackson M; Indans I; Loizu G; Navaratnam V; Pentreath V; Phillips B; Stemplewski H; Stewart J
    Altern Lab Anim; 2002; 30(4):365-406. PubMed ID: 12234245
    [No Abstract]   [Full Text] [Related]  

  • 4. Animal testing: more than a cosmetic change.
    Abbott A
    Nature; 2005 Nov; 438(7065):144-6. PubMed ID: 16281001
    [No Abstract]   [Full Text] [Related]  

  • 5. Summary: EU standards measurements and testing project PL95-3407. Development of a standardised in vitro methodology for hepatic and renal toxicity testing.
    Hartung T
    Altern Lab Anim; 2001; 29(4):493-5. PubMed ID: 11565511
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel advanced in vitro methods for long-term toxicity testing: the report and recommendations of ECVAM workshop 45. European Centre for the Validation of Alternative Methods.
    Pfaller W; Balls M; Clothier R; Coecke S; Dierickx P; Ekwall B; Hanley BA; Hartung T; Prieto P; Ryan MP; Schmuck G; Sladowski D; Vericat JA; Wendel A; Wolf A; Zimmer J
    Altern Lab Anim; 2001; 29(4):393-426. PubMed ID: 11506637
    [No Abstract]   [Full Text] [Related]  

  • 7. European Commission responds to chemical testing story.
    English M
    Nature; 2010 May; 465(7297):420. PubMed ID: 20505708
    [No Abstract]   [Full Text] [Related]  

  • 8. Initiatives to decrease redundancy in animal testing of pesticides.
    van Ravenzwaay B
    ALTEX; 2010; 27(3):112-114. PubMed ID: 21113565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRAG working group 6. Guidelines for the evaluation of eye irritation alternative tests: criteria for data submission. Interagency Regulatory Alternatives Group.
    Scala RA; Springer J
    Food Chem Toxicol; 1997 Jan; 35(1):13-22. PubMed ID: 9100812
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation of alternative methods for toxicity testing.
    Bruner LH; Carr GJ; Curren RD; Chamberlain M
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):477-84. PubMed ID: 9599695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a need in regulatory toxicity testing for evaluating chemicals at doses eliciting general toxicity?
    Chahoud I; Grote K
    Toxicology; 2016 Jul; 363-364():46-7. PubMed ID: 27430607
    [No Abstract]   [Full Text] [Related]  

  • 12. Developments on the implementation of the Three Rs in research and education.
    van Zutphen LF; van der Valk JB
    Toxicol In Vitro; 2001; 15(4-5):591-5. PubMed ID: 11566596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity testing: the need for new maps for the future.
    Balls M
    Altern Lab Anim; 2011 Oct; 39(5):417-8. PubMed ID: 22103936
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent developments in in vitro toxicology: perspectives of European research and Tox21.
    Marchan R; van Thriel C; Bolt HM
    Arch Toxicol; 2013 Dec; 87(12):2043-6. PubMed ID: 24221536
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory toxicology in the twenty-first century: challenges, perspectives and possible solutions.
    Tralau T; Oelgeschläger M; Gürtler R; Heinemeyer G; Herzler M; Höfer T; Itter H; Kuhl T; Lange N; Lorenz N; Müller-Graf C; Pabel U; Pirow R; Ritz V; Schafft H; Schneider H; Schulz T; Schumacher D; Zellmer S; Fleur-Böl G; Greiner M; Lahrssen-Wiederholt M; Lampen A; Luch A; Schönfelder G; Solecki R; Wittkowski R; Hensel A
    Arch Toxicol; 2015 Jun; 89(6):823-50. PubMed ID: 25820917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and regulatory acceptance of alternatives.
    Hill RN; Stokes WS
    Camb Q Healthc Ethics; 1999; 8(1):73-9. PubMed ID: 9924621
    [No Abstract]   [Full Text] [Related]  

  • 17. Validation is a key theme in this issue of ALTEX.
    von Aulock S
    ALTEX; 2011; 28(1):1. PubMed ID: 21404727
    [No Abstract]   [Full Text] [Related]  

  • 18. Statistical planning and analysis considerations in the evaluation of in vitro alternatives to whole animal use for eye irritation testing.
    Feder P; Carr G; Holzhütter HG; Lovell D; Springer J
    Food Chem Toxicol; 1997 Jan; 35(1):167-74. PubMed ID: 9100820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards an integrated in vitro strategy for repeated dose toxicity testing.
    Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
    Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
    [No Abstract]   [Full Text] [Related]  

  • 20. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies.
    Blaauboer BJ
    Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.